Metabolic & Fat Loss · Research Use Only
GLP-2 TZ
Also known as: Dual GIP/GLP-1 receptor agonist
GLP-2 TZ is a dual-incretin research peptide studied for agonism at both the GIP and GLP-1 receptors — the dual-agonist (tirzepatide-class) mechanism used in metabolic research.
View GLP-2 TZ product →What is GLP-2 TZ?
GLP-2 TZ is our designation for a dual-incretin research peptide that acts as an agonist at two receptors at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1. This dual-agonist approach is the tirzepatide-class mechanism studied in metabolic research.
This tirzepatide-class compound is popularly associated in metabolic-research and weight-management circles as a dual GIP/GLP-1 agonist reputed for appetite and body-weight effects.
Purported Benefits & Research Focus
GLP-2-TZ belongs to the tirzepatide class of dual GIP and GLP-1 receptor agonists, popularly discussed for its purported dual-pathway approach to appetite suppression and metabolic support.
Researchers are investigating its reputed effects on satiety, glucose handling, and body composition, and the weight-management community anecdotally associates dual agonists with strong reductions in food intake.
These outcomes are subjects of active clinical and preclinical investigation and considerable community interest, and nothing here constitutes medical advice.
How dual-incretin peptides are studied
In preclinical research, dual GIP/GLP-1 receptor agonists are investigated for how simultaneous activity at two incretin receptors affects signaling and metabolic markers in laboratory and animal models, compared with single-receptor agonists.
Handling, reconstitution & storage
Supplied lyophilized, stored at -20°C protected from light. Reconstituted with bacteriostatic or sterile water for research, then held at 4°C short-term or aliquoted at -80°C.
Not sure which solvent to use? See the reconstitution guide for a per-peptide breakdown of bacteriostatic vs acetic acid water.
Frequently asked questions
What receptors does GLP-2 TZ act on?
It is a dual agonist at the GIP and GLP-1 incretin receptors — the tirzepatide-class mechanism studied in metabolic research.
How does GLP-2 TZ differ from a GLP-1 agonist like Semaglutide?
Semaglutide targets the GLP-1 receptor alone; GLP-2 TZ is a dual agonist that also targets the GIP receptor. Researchers compare single- vs multi-receptor agonism in metabolic models.
References
Related research peptides
Shop research-grade GLP-2 TZ, HPLC-tested with a COA on every batch.
View GLP-2 TZ →All information here is provided for laboratory and research reference only. Products are sold strictly for in-vitro research and development and are not for human or veterinary use.